INTRODUCTION
In another paper (Kulcsir Gy. Theoretical and Literary Evidences for the Existence of the Passive Antitumor Defense System. Manuscript in preparation.) we expounded a hypothesis about a Passive Anliturnor Defense System (PADS) which is supported by many epidemiological and clinical observations, as well as other literary data. Briefly, the well-known observations that full-blown AlDS is associated with substantial loss of virtually all cellular and humoral immune response^'.^ are unquestionably evidenced by rejection-free renal graft survival in a patient with AlDS despite the significant and prolonged withdrawal of the usual immunosuppressive agents 7 . In spite of all these and contrary to expectation, the incidence of only a few kinds of tumor increases in patients with AIDS (mainly Kaposi's sarcoma and non-Hodgkin's l y r n p h~m a )~~~ and even in the development of tumors in question the degree of immunosuppression seems not to be a critical fa~tor'"'~. To take also into account the similar observations made in other immune deficiency di~eases'~.'~ and immunosuppressed it can be stated that the known immune system is not or not the only mechanism that prevents the development of tumors. This fits in well with findings that the majority of clinically relevant tumors are not or are only weakly immunogeni~~'~.
There are two possibilities to explain that tumors do not develop in the majority of population during their lifetime despite the ineffectiveness of the known immune system against the majority of tumors. The first possibility is that there is no defense mechanism against non-immunogenic tumors; that the rise of a cancer cell is only a rare singular event but a tumor may develop from all cells arising. This assumption includes the high vitality of these cancer cells under any conditions. However, this contradicts the observations that the cell death rate is still high within non-necrotic tumor tissue" and that 70% to 90% of newly produced tumor cells in humans die spontaneously by a mechanism that is yet poorly understood 2 ' and only a very small percentage (<0.01%) of ------circulating tumor EIICcZiE7iiittaremetastatic colonies n . The other possibility is that cancer cell formation is quite common but the majority of cells are not able to multiply to produce a tumor because they die shortly after they arise. The reasons for this may either be entirely random effects or the action of a systcmatic defense system. The former ones can be excluded because were cell death an absolutely accidental event, the simultaneous development of a number of primary tumors in organs should be a relatively frequent occurrence. However, the development of even double synchronous primary tumors is rather rarez3'''. Consequently, the death of non-immunogenic cancer cells can only be explained by the existence and effect of a hitherto unknown defense mechanism.
It is obvious that the components of an antitumor defense system must be in the circulatory system. On the basis of literary data, it can be assumed that the effective agents of this defense mechanism come from small molecules occurring in the circulatory system (amino acids, monosacharides, nucleobases, vitamins, membrane permeable intermediates of the cell metabolism, etc.). Certain features of these compounds make them suitable for this role. They can reach and enter all cells because they are components of the circulatory system and their presence is fundamental for normal cell functions. Their intake by normal cells is regulated. However, it is well documented that their intake by tumor cells is increased, unregulated and proportional to their a~a i l a b i l i t y~~~~' .
Thus, the tumor cells have a reproductive advantage over their normal neighhors in the competition for these essential substratesZ*". According to our speculation, this feature of tumor cells, i.e. that they can accumulate unregulatedly certain substances of the circulatory system, provide an advantage for them over normal cells only when there are many tumor cells and they have to compete with normal cells for these substances. The same feature, i.e. the unregulated uptake of these substances, may be highly disadvantageous, even fatal when there is no need for competition between cells because there are plenty of the substances in question. It is well known that -+ w w~k & f e r _ l a r g e J~r m~o r m a l cells.
However they differ only in degree, not in kind.
To the hest of our knowledge, thcre is no absolute, qualitative difference between normal and tumor cells at all. This precludes the possibility that a single molecule can kill the tumor cells selectively. To test this hypothesis, we selected five substances (tryptophan, tyrosine, methionine, malate, ascorbate) of the circulatory system as possible participators of the hypothetical defense system on the bases of literary data and theoretical considerations not detailed in this paper. We found that the mixture of them is really toxic for tumor cells and they increase the effect of each other synergistically. Then we selected experimentally eight additional substances that could potentiate synergistically the effect of the former five and examined the effect of a mixture containing the above mentioned five plus eight materials on different tumor and a normal cell line. We also investigated the in vivo effect of the above mentioned substances and demonstrated that it could inhibit the growth of Sp210-Ag14 mouse myeloma and HeLa human cervix epithelioid carcinoma in mice. These findings support our hypothesis and it can be stated that these substances occurring together in the living system can destroy a certain number of cancer cells in the body even if their concentrations are in physiological range. 
MATERIALS AND METHODS

Materials
Adenine, L-arginine, L-phenylalanine, L-histidine, L-tryptophan, L-tyrosine, L-methionine, 2-deoxy -D-ribose, oxalacetic acid, L(-)malic acid, d-biotin,
Cytotoxicity Assay
The toxicity was assessed by adding the tested compounds dissolved directly in the applied medium in the indicated concentrations specified under figures to cultures in %-well micro plates. Bacause ascorbic acid has short half-life in culture 3 ' it was added to culture once every 24 h' ' in the indicated amounts. To avoid the effect of pH, the solutions -except for ascorbic acidand mediums were incubated overnight in a humidified atmosphere of 5% CO, at 37°C before use. Immediately before use, 5 mM solution of ascorbic acid was made by using the appropriate medium incubated overnight and this solution was further diluted with the same medium to the working concentration. In the case of Sp210-Ag14 and K562 lines, the logarithmically growing cells were harvested from the medium and resuspended to a final concentration of 4x10' cells of Sp210-Ag14 and 2x104 of K562 in 250 p1 appropriate medium per well containing the tested materials in the indicated concentrations. In the case of HeLa, HEp-2, Vero and Caco-2 cell lines, the cultured cells were harvested from 75% confluent tissue culture flasks with 0.2% trypsin, 0.025% versene solution and resuspended in the appropriate medium at a density of 10' cells/ml. Aliquots (100 pi) -in the case of Caco-2, 100 p1 and 50 p1 -were dispensed into 96-well micro plates, made up to 250 p1 with the appropriate medium and incubated for 24 h. Then the medium was gently discarded and replaced with 250 p1 fresh medium containing the tested compounds in the indicated concentrations. All kinds of cells were allowed to proliferate for 48 h.
The number of viable Sp210-Ag14 and K562 cells was then counted microscopically with the trypan blue dye exclusion method. The viability of Caco-2 cells was assessed with the 3-(4,s-dimethylthiazol-2-yl)-2,sdiphenyltetrazolium bromide (M'IT) colorimetric assay". Because of disturbing effect of the tested compounds the modified assay was used 3 '. In brief, after 48 h incubation the medium was removed from the wells and the cells were washed with sterile PBS'. To the cells in each well was added 50 pl of a 5 mglml sterile filtered solution of M l T in the applied medium.
After incubating the plate for 4 h in 5% CO, at 37"C, the untransformed MTT was removed from the wells and the cells were washed with PBS. In all cases, the addition and removal of solutions were made carefully not to disturb the attached cells. Then 50 p1 isopropanol was added to all wells of the plate and thoroughly mixed in order to solubilize the formazan crystals. The quantity of formazan product formed was assessed by its absorbance at 550 nm on a Dynatech MR7000. Peripheral wells of each plate were utilized for blank (N = immediately before use and injected at 6.00, 9.00, and 12.00 am.; 3.00, 6.00, and 9.00 p.m. on each treatment day in a volume of 0.2 ml.
Determination of the Tumorigenicity of SpYOAg14 Mouse Myeloma Cells
Tumorigenicity was assessed by i.p. injection of varying numbers of Sp210-Ag14 mouse myeloma cells into BALBIc mice (3 mice1 group). The mice were monitored daily for mortality39.
Evaluation of Antiturnor Activity in i.p. Tumor Model
BALBIc mice (10 micelgroup) were injected i.p. with 5 X 104 Sp210-Ag14 mouse myeloma cells suspended in 0.2 ml RPMI 1640 on Day 0. The solution used for treatment was given i.p. daily according to the defined schedule from Day l after tumor inoculation for 10 days. Tumorbearing control mice were given injections of 0.2 ml PBS'. Mice were monitored daily for mortality. Efficacy of the solution used for treatment was expressed as the percentage increase in median survival time of treated over control tumor-bearing mice (TIC%)''. The log,, cell kill was calculated from the formula (T-C) 13.32 X T,, where T and C are the survival times for 50% of the animals in days for the treated and the control groups, respectively; 3.32 is the number of cell doublings per log of cell growth; and T, is the doubling time of Sp210-Ag14 mouse myeloma cells 4 '. The in vivo tumor doubling time for Sp210-Ag14 cells was estimated from semilogarithmic plots of data of tumorigenicity experiment, where the number of cells in the inoculum was plotted on the ordinate in logarithmic scale versus the survival times in days for 50% of the animals on a linear abscissa 4 '.
Determination of Cell Number in Ascitic Fluid
BALBIc mice (5 miceigroup) were injected i.p. with 5 X 104 Sp210-Ag14 mouse myeloma cells suspended in 0.2 m1 RPMI 1640. One day later the treatment was started. The solution used for treatment was given i.p. for 10 consecutive days amrding to the defined schedule. Tumorbearing control mice were given injections of 0.2 m1 PBS. After finishing the treatment, the mice were sacrificed by cervical dislocation, the skin was opened, and the ascitic fluid was sucked and stored separately. The peritonea1 cavity was washed twice with 5 m1 RPM1 1640 medium and the cell-containing fluid was collected. After centrifugation, the cells were resuspended in 5 ml RPM1 1640 medium and were counted. ascorbate as a final concentration in a well. It appears ( Fig. 1 ) that this four component mixture has significant cytotoxic effect on tumor cells because the cell number was only 27.2% compared to untreated cells. By increasing the amount of the fifth compounds the cell death further increased. For example, the additional tryptophan in 0.5 mM concentration decreased the cell number from 27.2+2.2% of the untreated value to 8.5+0.6% (black column). The same amount (0.5 mM) of tryptophan, when it was used without the other four substances, even slightly increased the proliferation of cells (white column). The differences between mixtures containing four components and mixtures containing five components and having the fifth components in the highest indicated concentration were significant (in the cases of malate, tryptophan and methionine P<0.01, in the cases of ascorbate and tyrosine P<0.001). The changes in different degrees of the white and black columns (in the cases of tryptophan and tyrosine even the opposite one) with the increasing amounts of the fifth materials prove the synergistic effect, and the black columns demonstrate the powerful tumor cell killing effect of the mixtures.
Effects of Various Compounds of the C i u l a t o r y System on the Effect of Five Component Mixture on the Survival of Sp210-Ag14 Mouse Myeloma Cells
To be able to detect the potentiating effect of the different compounds, the concentration of components of the five component mixture was set to 75% of their highest concentration used in the previous experiment. Thus, the mixture containing 0.375 mM tryptophan, 1.5 mM tyrosine, 0.56 mM methionine, 3.75 mM malate and 0.3 mM ascorbate as a final concentration in a well decreased the cell number to 47.8+2.8% compared to untreated cells. Of the 66 compounds examined, 9 compounds (adenine, Larginine, L-phenylalanine, L-histidine, 2-deoxy-D-ribose, d-biotin, pyridoxine, riboflavin and oxaloacetate) potentiated significantly (P<0.001, for oxaloacetate P<0.01) the effect of the five component mixture (Fig. 2) . Using the above substances singly in the indicated concentration none of them had cell proliferation-decreasing effect, in fact, some of them even slightly increased the cell number compared to untreated cells (data not shown). Thus it can be stated that these compounds potentiated in a synergistic manner the effect of the five component mixture in killing tumor cells. (Fig. 4) that the number of untreated cells (filled squares) and of cells treated with the control mixture (filled triangles) increased exponentially. At the same time, the number of cells treated with thirteencomponent active mixture (filled circles) decreased compared to starting value. In 48 hours the number of cells untreated and of the cells treated with 100% control mixture increased from a starting number of lBx103 to 754xlV (584% of starting) and to 610x103 (473% of starting), respectively. Over the same period, the number of cells treated with 100% thirteencomponent active mixture decreased from the starting value to 30x103 (23.3% of starting). This means that about 100,000 cells were killed by the active mixture. None of the components of active mixture had cytotoxic effect on cancer cells when they were used singly in the same amount as in active mixture (data not shown). This demonstrates that they increase the effect of each other synergistically. Osmotic effect: a nonspecific consequence of the overload of substances, ammonium toxicity or amino acid imbalance, can be excluded as the causes of cellkilling effect because the control mixture was not cytotoxic for the cells. The amount of catalase (Sigma, C-40) used was 2000 Utml". This amount did not decrease significantly the effect of either mixture (data not shown).
Effects of Various Counter Ions on the Thirteen-component Active Mixture Mediated Inhibition of Sp2iO-Agl4 Mouse Myeloma Cell Growth
To find out whether counter ions have any role in the effects of the mixtures, experiments were carried out where K* or CaZ' were used instead of Na' or sulfate instead of chloride. There were not any significant differences between the effects of mixtures using different counter ions. In fact, the results were essentially the same (data not shown).
Effects of Compounds of the Circulatory System Found Ineffective on the T h i icomponent Active Mixture Mediated Inhibition of Sp210-Agl4 Mouse Myeloma Cell Growth
To find out whether the compounds of the circulatory system found ineffective in our experiments (Fig. 2) can influence the effect of substances found effective, we performed experiments where the cultures contained 20% or 40% thirteen-component active mixture together with an additional 60% and 40% control mixture, respectively. Thus, the osmolality was equal with a 80% mixture in both cases. The cell killing effect was exactly the same as in the case when only 20% or 40% thirteen-component active mixture was used (data not shown).
Comparison of the Effects of Control Mixture and Thirteencomponent Active Mixture for Four Established Cell Lines
It can be seen (Fig. 5) A dose dependency was found between the number of cells injected and survival time, with survival times ranging from means of 11 to 22 days following injection of 2 . 2 x l e to 1 X l@ cells, respectively (Fig. 7) . Mice developed abdominal distention 3 to 4 days before death. At autopsy, 4 to 6 m1 of ascitic fluid was present in the peritonea1 cavity. The treatment with solution of the thirteencomponent active mixture given in "Materials and Methods" increased the survival time of the mice injected i.p. with SpUO-Ag14 cells (Fig. 8) . The difference between mean survival time of control (12.920.6 days) and treated (18.9d.5 days) group is highly significant (P<0.001). The TIC% calculated from the median survival time of control (13.5 days) and treated (20 days) group is 148.1%. Comparison of the 50% survival times (19 days) in the group of animals heated with the 50% survival times 
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The treatment with solution of the thirteencomponent active mixture given in "Materials and Methods" decreased the growth of tumors in the BALBIc nude mice injected s.c. with HeLa cells (Fig. 9) . The mean relative tumor volumes of the control (filled circles) and treated (filled squares) groups differed significantly (P<0.05) in all cases. The TIC% was less than 42% at each evaluation. The least value was 35.7%. The mean growth delay was 14 days. The weight loss of control (-5.5+3.1%) and treated group (-7.6?3.2%) did not differ significantly. system besides the known immune mechanisms. The action of this defense system is the reason that only a few kinds of tumor develop when the activity of the known immune system is decreased (in AIDS or in other immune deficiency diseases) or suppressed (in organ allograft recipients). This defense system causes that tumors do not develop in the majority of population during their lifetime, although the majority of the clinically relevant tumors are not or only weakly immunogeni~~'~. We assumed that the effective agents of this defense mechanism are certain small molecules occurring in the circulatory system. These molecules can enter both normal cells and tumor cells. However, their intake by nonnal cells is regulated, but by tumor cells it is unregulated and proportional to their a~ailability~~'. We assumed that some of these substances together, by increasing the effect of each other synergistically, can kill the tumor cells if they can reach enough high concentration in the cells. simultaneously exceeds a critical value at which the divisions of the cells compensate for the killing of cells by PADS and the cells are nonimmunogenic than it is most likely that a tumor develops.
On the bases of literary data and theoretical considerations not detailed in this paper, we selected L-tryptophan, L-tyrosine, L-methionine, L(-)date and L-ascorbate as possible "killer" molecules. Examining the effect of them singly and in combination on Sp210-Ag14 mouse myeloma cells in vitro (Fig. 1) we found that they could really act in the supposed synergistic manner. To examine whether only these five compounds correspond to our assumption, or if some other substances occurring in the circulatory system can potentiate the effect of them as well, we tested 66 materials (Fig. 2) . Nine of them, namely, L-arginine, L-phenylalanine, L-histidine, 2-deoxy-D-ribose, d-biotin, pyridoxine, adenine, riboflavin and oxaloacetate were found effective. It also agrees with our assumption that according to literature these compounds, except for 2-deoxy-D-ribose, are accumulated by tumor cells zs "'. Because the concentration of substances was chosen to be ineffective when they were used singly in the same concentration, the observed potentiating effects were in all cases the result of a synergistic interaction of the participating substances. The effect of oxaloacetate has only conceptual importance, since its concentration in the serum is very low compared to malate, and it is converted in the cells immediately to malate. Thus, it was not interesting regarding our starting hypothesis and we did not use it in our further experiments.
However its effect was interesting in a theoretical respect. In our theoretical considerations selecting malate as possible killer molecules we used the finding of Moreadith and Lehninger4', t h a t t h e e x t r a -and intramitochondrial malate has a different fate in tumor cells. Our results support their observation since oxaloacetate is the only intermediate of citric acid cycle that cannot readily cross the inner mitochondrial membrane and be converted immediately into-malate in cytosol and since the other intermediates of citric acid cycle, which can readily enter mitochondria and can be c o n v e r t e d i n t o m a l a t e m a i n l y intramitochondrially, were not found effective in our experiments (Fig. 2) .
Comparing the effect of different amounts (expressed as percentage) of mixture containing the original five components selected on a theoretical bases and a mixture diluted in the same percentage containing the above five substances plus the eight experimentally selected compounds, the latter was found more effective than the former one (Fig. 3) . Because certain brands or even lots of these substances can be contaminated and thus toxic, alone or in select combinations, we repeated the above experiments using different commercial products (obtained fmm Sigma, from Sewa and from Reanal) and the result was the same in all cases (data not shown). We used in all other experiments cell culture tested biochemicals purchased from Sigma Chemical Co. (St. Louis, MO) which were the purest compounds available for these kinds of experiments. At the same time, we used the best quality biochemicals only for active mixture and the components of the control mixture were obtained from different sources and in diiferent quality, as it was described in "Materials and Methods". In spite of these, the control mixture was not cytotoxic for any tumor cell lines at any amount. On the other hand, the thirteen-component active mixture was toxic both in vitro and in vivo only for different tumor cells and not for normal cells. On this basis, we think that the probability that contaminants have a significant role in the obtained effects is much less than the probability that the biochemicals themselves acted.
There are many publication^'^^^'^""^ about the optimization of composition of different tissue culture media. In opposition to us, they investigated the environment in which the different cells (malignant and normal) can growth ideally. They found that "all the amino acids are more or less inhibitory at 10-20 mM concentrations". They tested the toxicity of the substances singly and found that the reason of toxicity was "amino acid imbalance and ammonium toxicity". We determined the nontoxic amounts of all substances one by one by preliminary experiments and used these amounts in our experiments. Thus, the 100% thirteencomponent active mixtures in the experiments contained their components in such amounts in which they could not decrease the cell number compared to untreated cells when they were used singly. Naturally this was even more true for the 80%, 60%, etc., mixtures, in which the amounts of active materials were 20%, 40%, etc., less than the starting value. Thus, it can be stated that the cell killing effect was not caused by the individual toxicity of any components but it was strictly caused by the synergistic interaction of the given substances. On the other hand, in all experiments we used control mixtures that were composed of the same amounts of physiologically and chemically similar butaccording to our previous experiments (Fig. 2) &effective compounds (succinate, amino acids, vitamins, hypoxanthine and ribose) in the same dilution as the corresponding thirteen-component active mixture. Thus, the possibility that the measured effect in the experiments was a result of an osmotic effect or an aspecific overload of nutrients or an amino acid imbalance or ammonium toxicity could be excluded. Since the control mixtures also contained thirteen components it can also be excluded that the difference between mixtures containing five and thirteen compounds was caused by the increase of osmolality. In addition, we found the thirteen-component active mixture effective not only in tissue culture but also in vivo.
We demonstrated (Fig. 4) that the thirteencomponent active mixture destroyed the majority of Sp210-Ag14 mouse myeloma cells in 48 hours, whereas the control mixture only slightly influenced the proliferation of the same cells compared to untreated cells. The death of about 100,000 tumor cells proved that the synergistic interaction of the given substances did not only cause an inhibition of cell proliferation but it really killed the cells.
There was no significant difference at all between active mixtures containing the same thirteen compounds but different counter-ions (calcium or potassium instead of sodium and sulfate instead of chloride). Because the results with or without catalase were the same, it can also be excluded that the observed effect was caused by toxic hydrogen peroxide that can form by the action of light and oxygen on some s~bstances~'~'. The above results demonstrated that the measured cell killing effect is a fundamental feature of the mixture of the given substances. The effect of active mixtures did not change when it was complemented by different amounts of control mixture. This demonstrated again that the cell death was not caused by an imbalance. This finding also evidenced that the other compounds of the circulatory system could not antagonize the effect of active suhstances. Thus, the selected substances can act in physiological conditions, too.
Obviously, the various kinds of tumor cells differ from normal cells differently, and therefore it is presumable that the k i d and amount of the substances effective against them also differ to a certain extent. However, a mixture containing many compounds is probably effective against many or all kinds of tumor cells. Our further experiments render this speculation likely since the thirteen-component active mixture was found also significantly effective in vitro against K-562, HEp-2, HeLa (Fig. 5) and Caco-2 ( Fig. 6) cell lies compared to the control mixture. At the same time the above mentioned mixture had no cytotoxic effect against the Vero normal cell line (Fig. 5) ; it only slightly decreased the proliferation of the cells. The effect of the thirteen-component active mixture on different number of Caco-2 cells (Fig. 6 ) corroborates in another respect the speculation that, when the proportion between the number of tumor cells and the amount of "killer" molecules is under the above mentioned critical value, then the cells are destroyed by the given molecules. Being the HEp-2 a "hardy cell line that resists temperature, nutritional, and environmental changes without loss of viability" (ATCC Catalogue of Cell L i e s and Hybridomas, 1985) the obtained result proves again that the observed synergistic cell killing is not the result of a disturbing effect in the cell culture, but a fundamental feature of the mixture of the given substances. To exclude that the measured effect was caused by the employed detection method, three different methods were used to assay the cell viability. It is obvious that cell lines used in our experiments are not satisfactorily representative but our purpose was only to demonstrate that the mixture of the selected substances is effective against more than one tumor cell line and it is not toxic for normal cells. The latter one, considering also the nontoxic in vivo effect of the mixture, is evidenced. It is important to emphasize that in all experiments in vitro the concentration of the given substances was only about ten to one hundred times larger than the physiological concentration in the serum of the same s u b~t a n c e~~.~~'~. Considering the essentially direct proportion between the killed cells and the amount of mixture and dividing by a hundred the number of tumor cells per milliliter used in the experiments, it can be stated that the mixture of selected substances can kill a certain number of tumor cells when the concentration of the molecules is one hundredth of that used in the experiments, which is about the equivalent of their physiological concentration.
The aim of the in vivo experiments was to demonstrate that the substances of the circulatory system selected on the bases of starting hypothesis and found synergistically and selectively cytotoxic for tumor cells in vitro can also inhibit the growth of tumors in vivo. Considering the starting hypothesis, the most effective way of treatment would have been a continuous infusion, keeping the concentration of the selected substances in the circulatory system of the animals permanently on a fairly high level, to be abundant for tumor cells. For practical reasons we could use only a discontinuous, periodical treatment; thus, the effective level of substances in the serum could exist only for a short period. Although this treatment was not optimal to achieve a quantitative result and to demonstrate the total curative effectiveness of the thirteen-component active mixture, it was sufficient to get a qualitative view and to prove that mixture of the substances selected by us could also act in vivo and could destroy a certain number of tumor cells in the living system. This treatment was equal to the task because the demonstration of the latter one was our only purpose. First, we examined and found that the mixture of the above mentioned substances significantly increased the survival time of mice injected i.p. with SpZIO-Agl4 mouse myeloma cells (Fig. 8) by killing more than 2 logs (99%) of the cells. This result is even more noteworthy considering that SpWO-Agl4 mouse myeloma is a highly aggressive and fast proliferating cell line with 1 day in vivo doubling time as it was revealed by tumorigenicity experiment (Fig. 7) . The finding that the number of cells in the ascitic fluid of treated animals was significantly lower (about 2 logs cell kill) than in ascitic fluid of control animals excludes the possibility that the increase of survival time was caused by a simple mborating effect of the above substances. To show that the result was not due to a local effect (the i.p.-i.p. system) we experimented with an s.c. tumor model (HeLa human cervix epithelioid carcinoma). We found that the treatment significantly slowed down the tumor growth in treated animals compared to control ones (Fig.   9 ). It can be seen from the curve that the effectiveness of the treatment decreased with the increasing tumor volume. Considering the starting hypothesis, the probable explanation is that the proportion of the number of tumor cells and the amount of the substances reached by the discontinuous treatment was above a critical value during treatment. This is probably true also in the case of the other in vivo experiment made with mouse myeloma cells. Thus the number of tumor cells arising by cell division was higher than the number of cells killed by the given molecules. On the other hand, duration of the existence of substances in effective amounts ensured by one injected dose decreases as the number of tumor cells grows. This result fits well with the in vitro experiment (Fig. 6) that the effect of the mixture decreases as the number of tumor cells grows.
Body weight change is a generally used index to characterize the toxicity of a treatment. In our experiment the change in average body weight during treatment was not significant between the control and the treated group. Toxic death was not observed either during or after treatment, meaning that the substances in the given amount were not toxic. The reason for the small weight loss in both groups was probably the stress caused by frequent injections of the animals. d conclusion, considering the essentially direct proportion between the amount of mixture and the cell-killing effect in the in vitro experiments, the synergistic interaction of the substances, the number of killed cells at the given concentrations, the fact that the cell-killing effect is not antagonized by other substances of the circulatory system, the fact that the concentration of a given substance in the in vitro experiments was about ten to one hundred times larger than the physiological concentration in the serum of the same substance, the different effect of substances observed in vitro on normal and tumor cells, the non-toxic antitumor effects of the selected substances in vivo, it can be stated that these substances existing together in the living system can really destroy a certain number of cancer cells in the body under physiological condition when their concentrations are in physiological range. This supports our hypothesis that in the living systems a Passive Antitumor Defense System exists and the compounds found by us participate in this defense system. Obviously, the function of these molecules is generally not the protection of the organism. They play such a protective role only when tumor cells arise and exist. This protective role is very similar to the protective role of substances (i. e. fatty acids, porphyrins, lactic acid, etc.) which are bactericidal to certain pathogenic microorganisms 6 ', only the killing of tumor cells needs the collective, simultaneous, synergistic effect of more than one substance because the altered self cells do not differ to such an extent from the non-altered cells, like the nonself pathogenic microorganisms. The existence of PADS is also supported by many epidemiological and clinical observations, as well as other literary data as detailed in the mentioned paper (Kulcsh Gy. Theoretical and Literary Evidences for the Existence of the Passive Antitumor Defense System. Manuscript in preparation). For example, it was observed that the risk of cancer related to poor nutrition in the poorly fed Moslem populations of Central Asia may be considerable, even without other detrimental effects 6 '. Of course poor nutrition can negatively influence the known immune system too, but the majority of tumors not being immunogenic, this observation may be convincing evidence for the existence of PADS. It is probable that in the given system the about 10' cells are the critical value. The existence of PADS is also corroborated by the findings on over 50 separate naturally occurring murine mammary tumors that some organs in vitro rapidly and effectively diminish the number of live tumor cells66 and the inhibitory effects are dose dependent and due to the presence of soluble, dialyzable, non-immunologic agents of small molecular weight diffusing out of organs.
The existence of PADS and the knowledge of the participator molecules offer the possibility of practical employment. Considering the hypothesis and the results, this can be executed by keeping the concentration of the selected substances in the circulatory system permanently on a fairly high level, to be abundant for tumor cells. The possibilities of employment depending on dose are: for prophylaxis in the case of old people, different diseases, stress situations, malabsorption, alcoholism and in the case of populations which have a larger susceptibility to tumor because of hereditary features or for people with unusual lifestyles or modified diets; for prevention of tumor development in the case of AIDS patients and organ transplant recipients; for prevention of metastasis; for adjuvant, combined or direct treatment of patients having tumor. As it obviously follows from the theory, the treatment must be permanent in all cases. On the other hand the method can change from tablets to infusion, depending on the aim of the treatment, the probable number of tumor cells and thus the needed dose. This kind of treatment has remarkable advantages. First, the molecules of PADS are natural compounds. It is therefore probable that the tumor cells do not produce against them damage-recognition proteins and P-glycoproteins and thus it is also probable that resistance does not develop against them. Furthermore, they are without considerable adverse effects at the required and applicable dosage.
On the basis of preliminary observations it is probable that the substances found effective by us cause apoptosis, but the exact mechanism of their action and the application of treatments needs further investigation, which is in progress in our laboratory.
